×
About 605 results

ALLMedicine™ Keratoacanthoma Center

Research & Reviews  187 results

Low detection rate of human papillomavirus in patients with cutaneous squamous cell car...
https://doi.org/10.1684/ejd.2022.4332
European Journal of Dermatology : EJD; Baek YS, Kim YC et. al.

Dec 6th, 2022 - The role of human papillomavirus (HPV) in keratoacanthoma (KA) remains unclear. To identify possible differences in HPV DNA, detected by next-generation sequencing (NGS), between KAs and cutaneous squamous cell carcinomas (cSCCs), which may sugges...

Squamous Cell Carcinoma at Split Thickness Skin Graft Donor Site: A Case Report and Rev...
https://doi.org/10.1093/jbcr/irac137
Journal of Burn Care & Research : Official Publication Of... McCormick M, Miotke S

Sep 28th, 2022 - Squamous cell carcinoma (SCC) or keratoacanthoma (KA) development at split thickness skin graft donor sites is a documented but very rare entity. We describe a case in which a patient develops a lesion at his graft site seven weeks postoperatively...

Keratoacanthoma-Like Squamous Cell Carcinoma.
https://doi.org/10.1177/12034754221126124
Journal of Cutaneous Medicine and Surgery; Oon HH, Cheong CT

Sep 21st, 2022 - Keratoacanthoma-Like Squamous Cell Carcinoma.|2022|Oon HH,Cheong CT,|

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
https://clinicaltrials.gov/ct2/show/NCT02185560

Sep 21st, 2022 - This is a non-interventional, multi center post-authorization safety study that includes all patients diagnosed as Unresectable Differentiated Thyroid Carcinoma (DTC) and treated with Sorafenib within a certain period. The investigator should have...

Punked By the Punctum: Domestically Acquired Cutaneous Myiasis
https://www.mdedge.com/dermatology/article/257627/infectious-diseases/punked-punctum-domestically-acquired-cutaneous
Jeffrey Globerson, DO, Danielle Yee, MD et. al.

Sep 7th, 2022 - To the Editor: Cutaneous myiasis is a skin infestation with dipterous larvae that feed on the host’s tissue and cause a wide range of manifestations depending on the location of infestation. Cutaneous myiasis, which includes furuncular, wound, and.

see more →

Clinicaltrials.gov  1 results

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
https://clinicaltrials.gov/ct2/show/NCT02185560

Sep 21st, 2022 - This is a non-interventional, multi center post-authorization safety study that includes all patients diagnosed as Unresectable Differentiated Thyroid Carcinoma (DTC) and treated with Sorafenib within a certain period. The investigator should have...

see more →

News  54 results

Punked By the Punctum: Domestically Acquired Cutaneous Myiasis
https://www.mdedge.com/dermatology/article/257627/infectious-diseases/punked-punctum-domestically-acquired-cutaneous
Jeffrey Globerson, DO, Danielle Yee, MD et. al.

Sep 7th, 2022 - To the Editor: Cutaneous myiasis is a skin infestation with dipterous larvae that feed on the host’s tissue and cause a wide range of manifestations depending on the location of infestation. Cutaneous myiasis, which includes furuncular, wound, and.

TANS Syndrome: Tanorexia, Anorexia, and Nonmelanoma Skin Cancer
https://www.mdedge.com/dermatology/article/248258/nonmelanoma-skin-cancer/tans-syndrome-tanorexia-anorexia-and-nonmelanoma
Selli Abdali, MS, Alexandra Hamlyn, MD et. al.

Nov 4th, 2021 - The term tanorexia describes compulsive use of a tanning bed, a disorder often identified in White patients. This compulsion is driven by underlying psychological distress that typically correlates with another psychiatric disorder, such as anxiet.

Dr. Liebman on Toxicities of BRAF Inhibitors in Melanoma
https://www.onclive.com/view/dr-liebman-on-toxicities-of-braf-inhibitors-in-melanoma

Oct 6th, 2021 - Tracey Liebman, MD, assistant professor, Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, NYU Langone Health, discusses the toxicities associated with BRAF inhibitors in melanoma. Treatment with BRAF inhibitors can le...

Treatment-Related Dermatologic AEs in Melanoma Require Careful Management
https://www.onclive.com/view/treatmentrelated-dermatologic-aes-in-melanoma-require-careful-management

Oct 6th, 2021 - Tracey Liebman, MD Optimal management of treatment-related dermatologic adverse events (AEs) in patients with melanoma is essential for proper care, according to Tracey Liebman, MD. For the patients who develop nonspecific rash, pruritus or itch...

Updates in Targeted Combination Therapies for Melanoma
https://www.onclive.com/view/updates-in-targeted-combination-therapies-for-melanoma

Oct 6th, 2021 - Paul B. Chapman, MD Approximately 40% of melanoma cases harbor BRAF mutations that are able to be targeted, and with the advent of the combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) demonstrating impressive outcomes in patients w...

see more →